Published on
December 4, 2025
- 16:25 GMT
Mexico will receive new biosimilars for bone health through Saya Biologics in collaboration with Enzene, a CDMO partner
Collaboration aims to drive growth in the biosimilars market across Latin America and broaden access to biologic therapies for bone and joint diseases. MEXICO CITY, MEXICO CITY, MEXICO, December 4, 2025 /EINPresswire.com/ -- Saya Biologics (“Saya Bio …
Distribution channels:
Business & Economy, Companies
...
